Cargando...

A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis

Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration. Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing ther...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fox, Gregory J., Menzies, Dick
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2013
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4108107/
https://ncbi.nlm.nih.gov/pubmed/25134476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-013-0009-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!